Site‐specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates

Summary Background  Keloid disease (KD) is a common fibroproliferative disorder of unknown aetiology. T cells and macrophages are increased in KD and are thought to contribute to its pathogenesis. However, while a link between inflammation and fibrotic disorders is well known for other disorders, it remains undetermined in KD.

[1]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[2]  A. Bayat,et al.  Long‐term organ culture of keloid disease tissue , 2012, Experimental dermatology.

[3]  A. Bayat,et al.  Extracellular matrix molecules implicated in hypertrophic and keloid scarring , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  Michael Sorkin,et al.  Mechanical force prolongs acute inflammation via T‐cell‐dependent pathways during scar formation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  V. Jala,et al.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. , 2011, Immunity.

[6]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[7]  A. Bayat,et al.  Upregulation of Toll-like receptors (TLRs) 6, 7, and 8 in keloid scars. , 2011, The Journal of investigative dermatology.

[8]  Tomoko Mori,et al.  Keloid exacerbation associated with adult T-cell leukemia/lymphoma cell infiltration. , 2011, European journal of dermatology : EJD.

[9]  H. Ehrlich,et al.  Modulatory effects of connexin‐43 expression on gap junction intercellular communications with mast cells and fibroblasts , 2011, Journal of cellular biochemistry.

[10]  J. Colombel,et al.  Lymphatics, tertiary lymphoid organs and the granulomas of Crohn’s disease: an immunohistochemical study , 2011, Alimentary pharmacology & therapeutics.

[11]  C. Chizzolini,et al.  Fibrosis and immune dysregulation in systemic sclerosis. , 2011, Autoimmunity reviews.

[12]  N. Ayuob,et al.  Cell Talk: A Phenomenon Observed in the Keloid Scar by Immunohistochemical Study , 2011, Applied immunohistochemistry & molecular morphology : AIMM.

[13]  R. Byers,et al.  Quantum dots brighten biological imaging. , 2011, Progress in histochemistry and cytochemistry.

[14]  M. Si-Tahar,et al.  Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγt and LTi cells , 2011, The Journal of experimental medicine.

[15]  D. McGrouther,et al.  Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site‐directed therapy , 2011, The British journal of dermatology.

[16]  D. Evans,et al.  A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome , 2010, Journal of Clinical Pathology.

[17]  K. Khosrotehrani,et al.  Skin wound healing modulation by macrophages. , 2010, International journal of clinical and experimental pathology.

[18]  Luke Barron,et al.  Macrophages: Master Regulators of Inflammation and Fibrosis , 2010, Seminars in liver disease.

[19]  P. De Baetselier,et al.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. , 2010, Cancer research.

[20]  A. Mukhopadhyay,et al.  Comparative proteomic analysis between normal skin and keloid scar , 2010, The British journal of dermatology.

[21]  W. R. Lee,et al.  Kimura’s disease mimicking an earlobe keloid , 2010, Clinical and experimental dermatology.

[22]  R. Kimble,et al.  Microscopic inflammatory foci in burn scars: data from a porcine burn model , 2010, Journal of cutaneous pathology.

[23]  R. Paus,et al.  Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. , 2010, The Journal of investigative dermatology.

[24]  J. Roes,et al.  Differential Roles of Macrophages in Diverse Phases of Skin Repair , 2010, The Journal of Immunology.

[25]  A. Bayat,et al.  Molecular dissection of abnormal wound healing processes resulting in keloid disease , 2010, Wound Repair and Regeneration.

[26]  A. Bayat,et al.  The Influence of Surgical Excision Margins on Keloid Prognosis , 2010, Annals of plastic surgery.

[27]  S. Shi,et al.  Tumor-Like Stem Cells Derived from Human Keloid Are Governed by the Inflammatory Niche Driven by IL-17/IL-6 Axis , 2009, PloS one.

[28]  Scott N. Mueller,et al.  Stromal cell contributions to the homeostasis and functionality of the immune system , 2009, Nature Reviews Immunology.

[29]  G. Juckett,et al.  Management of keloids and hypertrophic scars. , 2009, American Family Physician.

[30]  E. Clementi,et al.  Inflammatory and alternatively activated human macrophages attract vessel‐associated stem cells, relying on separate HMGB1‐ and MMP‐9‐dependent pathways , 2009, Journal of leukocyte biology.

[31]  A. Cumano,et al.  Inflammation Recapitulates the Ontogeny of Lymphoid Stromal Cells1 , 2009, The Journal of Immunology.

[32]  J. Stark,et al.  Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. , 2009, The American journal of pathology.

[33]  Y. Inoue,et al.  Immunohistochemical characterization of the cellular infiltrate in localized scleroderma , 2008, International journal of dermatology.

[34]  P. Scott,et al.  Increased TGF‐β–producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[35]  T. Uchiyama,et al.  Involvement of OX40 ligand+ mast cells in chronic GVHD after allogeneic hematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[36]  M. Gaxiola,et al.  Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. , 2006, The Journal of clinical investigation.

[37]  P. Arck,et al.  Neuroimmunology of stress: skin takes center stage. , 2006, The Journal of investigative dermatology.

[38]  M. Cesta.  Normal Structure, Function, and Histology of Mucosa-Associated Lymphoid Tissue , 2006, Toxicologic pathology.

[39]  N. Araki,et al.  AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  V. Soumelis,et al.  Cutting Edge: Nonproliferating Mature Immune Cells Form a Novel Type of Organized Lymphoid Structure in Idiopathic Pulmonary Fibrosis1 , 2006, The Journal of Immunology.

[41]  T. Mcclanahan,et al.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.

[42]  S. Liao,et al.  Lymphoid organ development: from ontogeny to neogenesis , 2006, Nature Immunology.

[43]  M. Delehanty,et al.  Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[44]  M. Tsai,et al.  Mast Cells Enhance T Cell Activation: Importance of Mast Cell Costimulatory Molecules and Secreted TNF1 , 2006, The Journal of Immunology.

[45]  D. Messadi,et al.  Hypoxia-induced HIF-1 alpha accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt. , 2006, Experimental cell research.

[46]  R. Paus,et al.  Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. , 2005, The Journal of investigative dermatology.

[47]  M. Zabel,et al.  LYVE-1 expression on high endothelial venules (HEVs) of lymph nodes. , 2005, Lymphology.

[48]  T. Cupedo,et al.  Induction of secondary and tertiary lymphoid structures in the skin. , 2004, Immunity.

[49]  P. Chu,et al.  CD163: a specific marker of macrophages in paraffin-embedded tissue samples. , 2004, American journal of clinical pathology.

[50]  Y. Okayama,et al.  T Cell Proliferation by Direct Cross-Talk between OX40 Ligand on Human Mast Cells and OX40 on Human T Cells: Comparison of Gene Expression Profiles between Human Tonsillar and Lung-Cultured Mast Cells1 , 2004, The Journal of Immunology.

[51]  M. Longaker,et al.  Complex epithelial–mesenchymal interactions modulate transforming growth factor‐β expression in keloid‐derived cells , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[52]  H. Ehrlich,et al.  Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[53]  R. Mebius.  Organogenesis of lymphoid tissues , 2003, Nature Reviews Immunology.

[54]  F. Wood,et al.  [International clinical recommendations on scar management]. , 2002, Zentralblatt fur Chirurgie.

[55]  Hung Huynh,et al.  Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner. , 2002, American journal of physiology. Cell physiology.

[56]  C. Castagnoli,et al.  Role of T‐lymphocytes and cytokines in post‐burn hypertrophic scars , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[57]  K. Harding,et al.  Inflammatory-cell subpopulations in keloid scars. , 2001, British journal of plastic surgery.

[58]  M. Santucci,et al.  Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles , 2001, Virchows Archiv.

[59]  M. Longaker,et al.  Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. , 2001, Plastic and reconstructive surgery.

[60]  B. Antus,et al.  Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. , 2000, Cellular immunology.

[61]  M. Kurosawa,et al.  Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. , 2000, The Journal of allergy and clinical immunology.

[62]  D. Tobin,et al.  The human hair follicle immune system: cellular composition and immune privilege , 2000, The British journal of dermatology.

[63]  D. Jackson,et al.  LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.

[64]  C. Castagnoli,et al.  Functional analysis of T lymphocytes infiltrating the dermis and epidermis of post-burn hypertrophic scar tissues. , 1999, Burns : journal of the International Society for Burn Injuries.

[65]  C. Castagnoli,et al.  Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues. , 1997, Burns : journal of the International Society for Burn Injuries.

[66]  J. Garlick,et al.  Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. , 1997, Journal of immunology.

[67]  C. W. Martin,et al.  The role of lymphocytes in wound healing. , 1990, British journal of plastic surgery.

[68]  Koonin Aj.  THE AETIOLOGY OF KELOIDS: A REVIEW OF THE LITERATURE AND A NEW HYPOTHESIS. , 1964 .

[69]  R. Ogawa,et al.  Keloid and hypertrophic scar: neurogenic inflammation hypotheses. , 2008, Medical hypotheses.

[70]  A. J. Koonin.  THE AETIOLOGY OF KELOIDS: A REVIEW OF THE LITERATURE AND A NEW HYPOTHESIS. , 1964, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.